polyactin A

01/01/2015 - "Regimen of mannatide combined with sodium cantharidate vitamin B6 had better improvement in quality-of-life and symptom relief, with a lower side-effect incidence in treatment of malignant pleural effusions."
01/01/2015 - "To evaluate the efficacy of mannatide combined with sodium cantharidate vitamin B6 in the treatment of malignant pleural effusions. "
01/01/2015 - "Efficacy of mannatide combined with sodium cantharidate vitamin B6 in the treatment of malignant pleural effusions."

12/01/2011 - "To investigate the effect of mannatide injection (MI) in enhancing the efficacy of radiotherapy in two therapeutic schedules in mice bearing Lewis lung cancer. "
12/01/2011 - "[Mannatide enhances the efficacy of fractionated and unfractionated radiotherapy in mice bearing Lewis lung cancer]."

04/01/2014 - "The inhibitory rate of S180 tumors in mice treated with 40 mg/kg BSF-A reached 62.449%, which was the highest rate from the three doses administered; this may be comparable to mannatide. "
09/01/1989 - "Furthermore, more M type ANAE+ cells were seen in the peripheral area of the tumors in polyactin A-treated groups than in any other group. "
09/01/1989 - "Results showed that polyactin A could significantly inhibit the growth of transplanted S 180 tumor in mice. "
09/01/1989 - "[The effect of depletion depletion macrophages on tumor-suppressive activity of polyactin A]."
09/01/1989 - "In addition, marked hemorrhagic necrosis was seen in the polyactin A-treated tumor, and the area of necrosis was larger than that in the controls. "

06/01/2021 - "CD8+ T-cell percentage increases in diffuse large B-cell lymphoma patients receiving mannatide combined with standard regimens."

09/01/1989 - "In addition, marked hemorrhagic necrosis was seen in the polyactin A-treated tumor, and the area of necrosis was larger than that in the controls. "